Induced Tamoxifen Resistance is Mediated by Increased Methylation of E-Cadherin in Estrogen Receptor-Expressing Breast Cancer Cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Induced Tamoxifen Resistance is Mediated by Increased Methylation of E-Cadherin in Estrogen Receptor-Expressing Breast Cancer Cells
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-10-02
DOI
10.1038/s41598-019-50749-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SNAIL is induced by tamoxifen and leads to growth inhibition in invasive lobular breast carcinoma
- (2019) Emily A. Bossart et al. BREAST CANCER RESEARCH AND TREATMENT
- Endocrine and Targeted Therapy for Hormone-Receptor-Positive, HER2-Negative Advanced Breast Cancer: Insights to Sequencing Treatment and Overcoming Resistance Based on Clinical Trials
- (2019) Rola El Sayed et al. Frontiers in Oncology
- Epithelial mesenchymal transition and resistance in endocrine-related cancers
- (2019) Zoran Culig BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Tamoxifen Never Ceases to Amaze: New Findings on Non-Estrogen Receptor Molecular Targets and Mediated Effects
- (2018) Tatiana Anatolievna Bogush et al. CANCER INVESTIGATION
- Mechanisms of resistance in estrogen receptor positive breast cancer: overcoming resistance to tamoxifen/aromatase inhibitors
- (2018) Jamie N Mills et al. CURRENT OPINION IN PHARMACOLOGY
- Cadherin profiling for therapeutic interventions in Epithelial Mesenchymal Transition (EMT) and tumorigenesis
- (2018) Mintu Pal et al. EXPERIMENTAL CELL RESEARCH
- Altered DNA methyltransferases promoter methylation and mRNA expression are associated with tamoxifen response in breast tumors
- (2018) Rosa Jahangiri et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2015
- (2018) Kyu-Won Jung et al. Cancer Research and Treatment
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cyclin A2 regulates homologous recombination DNA repair and sensitivity to DNA damaging agents and poly(ADP-ribose) polymerase (PARP) inhibitors in human breast cancer cells
- (2017) Wei Wei Gu et al. Oncotarget
- Combinatorial bioactive botanicals re-sensitize tamoxifen treatment in ER-negative breast cancer via epigenetic reactivation of ERα expression
- (2017) Yuanyuan Li et al. Scientific Reports
- Functional role of miR-10b in tamoxifen resistance of ER-positive breast cancer cells through down-regulation of HDAC4
- (2015) Aamir Ahmad et al. BMC CANCER
- Epithelial-Mesenchymal Plasticity of Breast Cancer Stem Cells: Implications for Metastasis and Therapeutic Resistance
- (2015) Ming Luo et al. CURRENT PHARMACEUTICAL DESIGN
- Epithelial-mesenchymal transition and drug resistance in breast cancer (Review)
- (2015) JING HUANG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Epithelial-to-mesenchymal transition: What is the impact on breast cancer stem cells and drug resistance
- (2013) Paraskevi Mallini et al. CANCER TREATMENT REVIEWS
- Treatment of Estrogen Receptor-Positive Breast Cancer
- (2013) F. Lumachi et al. CURRENT MEDICINAL CHEMISTRY
- Epigenetic alterations in the breast: Implications for breast cancer detection, prognosis and treatment
- (2009) Amy M. Dworkin et al. SEMINARS IN CANCER BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search